None listed
Conditions
Interventions
Dietary Supplement : In case of experimental group, TabetriTM (10g/pack), a stick jelly type, is orally administered after meal (morning and evening), taken 1 pack at a time, twice a day for 12 weeks.
Sponsors
Nutri Biotech
Eligibility
Sex/Gender
All
Inclusion criteria
Inclusion criteria: 1) Patients who agree to participate in this experiment and write consent including the subject and the parent (or legal representative) 2) Patients who aged 4~12 years of both sexes 3) Patients who have had intermittent or persistent atopic dermatitis symptoms for more than 6 months 4) Patients with mide to moderate atopic dermatitis symptoms (SCORing of Atopic Dermatitis, SCORAD index range from 20 to 50)
Exclusion criteria
Exclusion criteria: 1) Pateints who had severe skin disease, systemic disease 2) Patients who had prior treatments associated with atopic dermatitis, including systemic antibiotics, corticosteroids, anti-histamines, immunosuppressant within 4 weeks prior to the study 3) Patients who administered medicine, herbal medicine, any health functional supplements to improve atopic dermatitis within 1 week 4) Patients who had phototherapy within 4 weeks prior to the study 5) Patients who plan to participate in another human body test during this experiment 6) Patients who participated in another human body test before this experiment within 4 weeks 7) Patients who is deemed by the examiner to be inappropriate for this experiment
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| SCORAD total score | — |
Secondary
| Measure | Time frame |
|---|---|
| SCORing of Atopic Dermatitis objective score;SCORing of Atopic Dermatitis subjective score;Investigator’s Global Assessment;Eosinophil count, inflammatory biomarker;Usage of topical steroids (Percentage and dose) | — |
Countries
Korea, Republic of
Contacts
Public ContactHye Jin Shin
Kyung Hee University Oriental Medicine Hospital at Gangdong
Outcome results
None listed